CRISPR Therapeutics Announces Transition of Bill Lundberg, MD – GlobeNewswire (press release)
Madison.com |
CRISPR Therapeutics Announces Transition of Bill Lundberg, MD
GlobeNewswire (press release) “Bill was instrumental in establishing our research operations and advancing our CRISPR/Cas9 platform from the research phase to clinical evaluation. On behalf of CRISPR Therapeutics, I thank Bill for his leadership and look forward to his continued … Why Crispr Therapeutics AG Stock Bolted Higher in January Crispr Therapeutics AG (NASDAQ:CRSP) Forecasted to Earn FY2022 Earnings of ($3.83) Per Share Uncovering the next great stocks: Riot Blockchain, Inc. (RIOT), CRISPR Therapeutics AG (CRSP) |
